8 results on '"Omorou M"'
Search Results
2. Ethnobotany of Pentadesma butyracea in Benin: A quantitative approach
- Author
-
Avocèvou-Ayisso, Carolle, primary, Avohou, T.H., additional, Omorou, M., additional, Dessou, G., additional, and Sinsin, B., additional
- Published
- 2012
- Full Text
- View/download PDF
3. Disco interacting protein 2 homolog A (DIP2A): A key component in the regulation of brain disorders.
- Author
-
Zhang B, Zhang X, Omorou M, Zhao K, Ruan Y, and Luan H
- Subjects
- Humans, Proto-Oncogene Proteins c-akt metabolism, AMP-Activated Protein Kinases metabolism, Nuclear Proteins genetics, Gene Expression Regulation, Brain Diseases, Follistatin-Related Proteins metabolism
- Abstract
Disco Interacting Protein 2 Homolog A (DIP2A) is expressed throughout the body and abundantly expressed in the brain tissue. It is activated by Follistatin-like 1 (FSTL1). Activated DIP2A interacts with several pathways, such as AMPK/mTOR and AKT pathways, to contribute to many biological processes, such as oxidative stress, transcriptional regulation, and apoptosis. Dysregulated DIP2A activation has been implicated in numerous processes in the brain. If the upstream pathways of DIP2A remain globally unexplored, many proteins, including cortactin, AMPK, and AKT, have been identified as its downstream targets in the literature. Recent studies have linked DIP2A to a variety of mechanisms in many types of brain disorders, suggesting that regulation of DIP2A could provide novel diagnostic and therapeutic approaches for brain disorders. In this review, we comprehensively summarized and discussed the current research on DIP2A in various brain disorders, such as stroke, autism spectrum disorders (ASD), Alzheimer's disease (AD), dyslexia, and glioma., Competing Interests: Declaration of Competing Interest The authors declare no conflicts of interest., (Copyright © 2023 The Authors. Published by Elsevier Masson SAS.. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
4. Hydrogen sulfide and its donors for the treatment of cerebral ischaemia-reperfusion injury: A comprehensive review.
- Author
-
Huang Y, Omorou M, Gao M, Mu C, Xu W, and Xu H
- Subjects
- Animals, Reactive Oxygen Species metabolism, Oxidative Stress, Cerebral Infarction drug therapy, Mammals, Hydrogen Sulfide metabolism, Reperfusion Injury drug therapy, Reperfusion Injury metabolism, Brain Ischemia drug therapy, Brain Injuries drug therapy
- Abstract
As an endogenous gas signalling molecule, hydrogen sulfide (H
2 S) is frequently present in a variety of mammals and plays a significant role in the cardiovascular and nervous systems. Reactive oxygen species (ROS) are produced in large quantities as a result of cerebral ischaemia-reperfusion, which is a very serious class of cerebrovascular diseases. ROS cause oxidative stress and induce specific gene expression that results in apoptosis. H2 S reduces cerebral ischaemia-reperfusion-induced secondary injury via anti-oxidative stress injury, suppression of the inflammatory response, inhibition of apoptosis, attenuation of cerebrovascular endothelial cell injury, modulation of autophagy, and antagonism of P2X7 receptors, and it plays an important biological role in other cerebral ischaemic injury events. Despite the many limitations of the hydrogen sulfide therapy delivery strategy and the difficulty in controlling the ideal concentration, relevant experimental evidence demonstrating that H2 S plays an excellent neuroprotective role in cerebral ischaemia-reperfusion injury (CIRI). This paper examines the synthesis and metabolism of the gas molecule H2 S in the brain as well as the molecular mechanisms of H2 S donors in cerebral ischaemia-reperfusion injury and possibly other unknown biological functions. With the active development in this field, it is expected that this review will assist researchers in their search for the potential value of hydrogen sulfide and provide new ideas for preclinical trials of exogenous H2 S., Competing Interests: Conflict of interest statement The authors declare that they have no competing interests., (Copyright © 2023 The Authors. Published by Elsevier Masson SAS.. All rights reserved.)- Published
- 2023
- Full Text
- View/download PDF
5. The forkhead box O3 (FOXO3): a key player in the regulation of ischemia and reperfusion injury.
- Author
-
Omorou M, Huang Y, Gao M, Mu C, Xu W, Han Y, and Xu H
- Subjects
- Humans, Forkhead Box Protein O3 genetics, Forkhead Box Protein O3 metabolism, Apoptosis genetics, Oxidative Stress, Ischemia, Reperfusion Injury genetics, Reperfusion Injury metabolism
- Abstract
Forkhead box O3 is a protein encoded by the FOXO3 gene expressed throughout the body. FOXO3 could play a crucial role in longevity and many other pathologies, such as Alzheimer's disease, glioblastoma, and stroke. This study is a comprehensive review of the expression of FOXO3 under ischemia and reperfusion (IR) and the molecular mechanisms of its regulation and function. We found that the expression level of FOXO3 under ischemia and IR is tissue-specific. Specifically, the expression level of FOXO3 is increased in the lung and intestinal epithelial cells after IR. However, FOXO3 is downregulated in the kidney after IR and in the skeletal muscles following ischemia. Interestingly, both increased and decreased FOXO3 expression have been reported in the brain, liver, and heart following IR. Nevertheless, these contribute to stimulating ischemia and reperfusion injury via the induction of inflammatory response, apoptosis, autophagy, mitophagy, pyroptosis, and oxidative damage. These results suggest that FOXO3 could play protective effects in some organs and detrimental effects in others against IR injury. Most importantly, these findings indicate that controlling FOXO3 expression, genetically or pharmacologically, could contribute to preventing or treating ischemia and reperfusion damage., (© 2023. The Author(s), under exclusive licence to Springer Nature Switzerland AG.)
- Published
- 2023
- Full Text
- View/download PDF
6. The relationship between miRNA-210 and SCN1B in fetal rats with hypoxic-ischemic brain injury.
- Author
-
Al-Ward H, Liu N, Omorou M, Huang Y, Chen W, Liu CY, Lv S, Murshed A, Shaher F, Li Y, Zhang Y, Lu L, Gao W, Sun YE, and Xu H
- Subjects
- Animals, Rats, Brain pathology, Neurons metabolism, Hypoxia-Ischemia, Brain genetics, Brain Injuries metabolism, MicroRNAs genetics, MicroRNAs metabolism
- Abstract
Hypoxic-ischemic brain injury contributes to major neurodevelopmental disorders and is one of the leading causes of seizures, which substantially results in neurodevelopmental impairments with long-lasting outcomes and is one of the main causes of death in neonates. We aimed to investigate the correlation between miRNA-210 and SCN1B, a voltage-gated sodium channel gene, in brain tissue of fetal rats with hypoxic-ischemic brain injury. We found that after 10 min of hypoxia-ischemia, all reperfusion groups showed different degrees of damage. The degree of the injury increased in all the groups after 30 min of hypoxia-ischemia. Those changes include changes in the pericellular lumen, capillaries in the cortex, erythrocytes, enlarged pericellular lumen, the enlarged pericapillary lumen in the cortex, edema around glial cells, enlarged gap to form multiple necrotic foci, deformation of neurons, and loss of cell structure. The expression levels of HIF-1α, miRNA-210, and HIF-1α mRNA were higher in the hypoxic-ischemic groups than that in the control groups, among which the expression levels in the severe group were higher than that in mild group. SCN1B is down-regulated in both the mild and severe groups, and the lowest level was found at 30 min after hypoxia in both groups. MiRNA-210 plays a role in the development of hypoxic-ischemic encephalopathy (HIE) by regulating the expression changes of SCN1B. The brain tissue of fetal rats in the hypoxic-ischemic animal model showed pathological changes of brain injury., (© 2023 The Author(s).)
- Published
- 2023
- Full Text
- View/download PDF
7. The emerging role of miR-653 in human cancer.
- Author
-
Omorou M, Huang Y, Liu N, Bafei SEC, Gao M, Mu C, Zhang L, and Hui X
- Subjects
- Gene Expression Regulation, Neoplastic, Humans, Male, Prognosis, Lung Neoplasms genetics, MicroRNAs genetics, Stomach Neoplasms
- Abstract
MicroRNAs (miRNAs) refer to a family of non-coding RNA with ~22 nucleotides in length. A high number of studies show evidence that deregulation in miRNAs expression could be implicated in the processes of many pathologies such as cancer, hypoxia, and stroke. Herein, we aimed to summarize the miR-653 expression level and molecular mechanisms through which it functions in human cancer. It was found that variations in miR-653 expression are linked to tumor aggressiveness and unfavorable prognosis in human cancer, and it plays an inhibitory effect in some types of cancer, such as breast, cervical, liver, renal, and lung cancers. In contrast, it plays an acceleratory impact in some other cancers, such as bladder and prostate cancers. In gastric cancer, the role played by miR-653 is still controversial and will need to be elucidated in future studies. Future studies could definitely establish targeting miR-653 as a novel strategy in human cancer, from diagnosis to effective treatment., (Copyright © 2022 Elsevier Ltd. All rights reserved.)
- Published
- 2022
- Full Text
- View/download PDF
8. Cystathionine beta-Synthase in hypoxia and ischemia/reperfusion: A current overview.
- Author
-
Omorou M, Liu N, Huang Y, Al-Ward H, Gao M, Mu C, Zhang L, and Hui X
- Subjects
- Cystathionine beta-Synthase metabolism, Cystathionine gamma-Lyase metabolism, Humans, Hypoxia, Ischemia, Reperfusion, Hydrogen Sulfide metabolism, Reperfusion Injury metabolism
- Abstract
Besides its presence in the liver, brain, pancreas, and kidney, Cystathionine beta-Synthase (CBS) is also found in many other tissues, where it acts through regulation of hydrogen sulfide (H
2 S) generation and homocysteine (Hcy) metabolism, to interact with other molecules during hypoxia and ischemia/reperfusion (I/R). Despite all the advances accumulated in decades of research on CBS, there are still controversies, and the role of CBS in many tissues during hypoxia and I/R is still unclear. Herein, we overviewed the expression level, the role, and the mechanism through which CBS interacts with other molecules during hypoxia and I/R processes in tissues of humans and other organisms. CBS appeared to be deregulated under hypoxia and I/R, after which it mostly conduces the reparation in the concerned tissue after damage; however, it has been described that CBS could also play pathological effects (exacerbating the damage). From all findings, it emerges that variations in CBS expression in these conditions depend on the organism, tissue, or subcellular localization, CBS could play both protective and pathological effects; and artificially controlling CBS expression may help to provide novel strategies for treatment or prevention of hypoxia and I/R -related injury., (Copyright © 2022 Elsevier Inc. All rights reserved.)- Published
- 2022
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.